DEVICES IN HEART FAILURE

Sunday, March 8, 2026

9:31 AM - 11:22 AM EST

Location: Georgetown

Moderator(s)

Phillip Adamson, MD

Chief Medical Officer
CVRx
Austin, Texas, United States

Disclosure(s): Abbott Labs: Stock-publicly held company (excluding mutual/index funds) (Ongoing); CVRx: Employee (Ongoing), Stock-publicly held company (excluding mutual/index funds) (Ongoing)
Navin K. Kapur, MD, FSCAI, FAHA, FACC

Professor of Medicine
Tufts Medical Center
Boston, Massachusetts, United States

Disclosure(s): Abiomed / Johnson & Johnson: Employee (Ongoing)
PL

Phillip H. Lam, MD

Advanced Heart Failure Cardiologist
MedStar Health

Disclosure(s): No financial relationships to disclose

Disclosure(s):

Phillip Adamson, MD: Abbott Labs: Stock-publicly held company (excluding mutual/index funds) (Ongoing); CVRx: Employee (Ongoing), Stock-publicly held company (excluding mutual/index funds) (Ongoing)

Navin K. Kapur, MD, FSCAI, FAHA, FACC: Abiomed / Johnson & Johnson: Employee (Ongoing)

Phillip H. Lam, MD: No financial relationships to disclose